BioBetter Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 37

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Investors
  • 8

BioBetter General Information

Description

Developer of a molecular farming platform designed to produce high-value bioactive proteins in plants for cosmetics and regenerative aesthetics applications. The company offers plant-engineered growth factors with enhanced stability and sustained biological activity across manufacturing and shelf life, enabling cosmetics and regenerative aesthetics manufacturers to incorporate reliable bioactive ingredients for skin and scalp formulations.

Contact Information

Website
www.biobetter.bio
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tel-Hai Industrial Park
  • Building 9, Galil Elyon
  • Tel-Hai
  • Israel
Primary Industry
Biotechnology
Other Industries
Other Agriculture
Other Commercial Products
Other Pharmaceuticals and Biotechnology
Vertical(s)
AgTech, Life Sciences
Corporate Office
  • Tel-Hai Industrial Park
  • Building 9, Galil Elyon
  • Tel-Hai
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioBetter Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC Cancelled Generating Revenue
6. Accelerator/Incubator 14-Sep-2023 Completed Generating Revenue
5. Later Stage VC (Series A) 13-Jul-2022 Completed Generating Revenue
4. Later Stage VC (Series A) 16-Dec-2020 Completed Generating Revenue
3. Seed Round 01-Jun-2019 Completed Generating Revenue
2. Accelerator/Incubator 18-May-2017 $964K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view BioBetter’s complete valuation and funding history, request access »

BioBetter Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Preferred A1
Preferred A
Ordinary A 15,000 $0.010000
To view BioBetter’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

BioBetter Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a molecular farming platform designed to produce high-value bioactive proteins in plants for cosmetics and
Biotechnology
Tel-Hai, Israel
37 As of 2026

Strasbourg, France
 

Kopavogur, Iceland
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioBetter Competitors (3)

One of BioBetter’s 3 competitors is Core Biogenesis, a Venture Capital-Backed company based in Strasbourg, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Core Biogenesis Venture Capital-Backed Strasbourg, France
ORF Genetics Venture Capital-Backed Kopavogur, Iceland
LipoTrue Science & Biotechnologies Private Equity-Backed Barcelona, Spain
You’re viewing 3 of 3 competitors. Get the full list »

BioBetter Patents

  • 9

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 6

    Pending

  • Expiring in next 12 mo

BioBetter Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026185840-A1 Growth factor-cellulose binding domain fusion proteins stabilized by polysaccharide-based particles Pending 03-Mar-2025
WO-2024154138-A1 Chimeric polypeptides comprising cbd and extracellular matrix (ecm) proteins or motifs thereof Inactive 19-Jan-2023
JP-2023538936-A Cellulose binding domain (cbd) cell effector protein (cep) chimera for tissue engineering Pending 23-Aug-2020
AU-2021330721-A1 Cellulose binding domain (cbd) cell effector protein (cep) chimera, for the tissue engineering Inactive 23-Aug-2020
CA-3189570-A1 Cellulose binding domain (cbd) cell effector protein (cep) chimera, for the tissue engineering Pending 23-Aug-2020 C07K14/475
To view BioBetter’s complete patent history, request access »

BioBetter Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioBetter Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
EIT Food Accelerator/Incubator
Jerusalem Venture Partners Venture Capital Minority
Milk & Honey Ventures Venture Capital Minority
Alpha Capital Anstalt Corporation Minority
Innovation Authority Government Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

BioBetter FAQs

  • When was BioBetter founded?

    BioBetter was founded in 2015.

  • Where is BioBetter headquartered?

    BioBetter is headquartered in Tel-Hai, Israel.

  • What is the size of BioBetter?

    BioBetter has 37 total employees.

  • What industry is BioBetter in?

    BioBetter’s primary industry is Biotechnology.

  • Is BioBetter a private or public company?

    BioBetter is a Private company.

  • What is BioBetter’s current revenue?

    The current revenue for BioBetter is .

  • How much funding has BioBetter raised over time?

    BioBetter has raised $18.9M.

  • Who are BioBetter’s investors?

    EIT Food, Jerusalem Venture Partners, Milk & Honey Ventures, Alpha Capital Anstalt, and Innovation Authority are 5 of 8 investors who have invested in BioBetter.

  • Who are BioBetter’s competitors?

    Core Biogenesis, ORF Genetics, and LipoTrue Science & Biotechnologies are competitors of BioBetter.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process